BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 11040069)

  • 1. It's insulin.
    Wegmann DR; Eisenbarth GS
    J Autoimmun; 2000 Nov; 15(3):286-91. PubMed ID: 11040069
    [No Abstract]   [Full Text] [Related]  

  • 2. Does GAD have a unique role in triggering IDDM?
    Baekkeskov S; Kanaani J; Jaume JC; Kash S
    J Autoimmun; 2000 Nov; 15(3):279-86. PubMed ID: 11040068
    [No Abstract]   [Full Text] [Related]  

  • 3. GAD, a single autoantigen for diabetes.
    von Boehmer H; Sarukhan A
    Science; 1999 May; 284(5417):1135, 1137. PubMed ID: 10366347
    [No Abstract]   [Full Text] [Related]  

  • 4. Disease prevention with islet autoantigens.
    Eisenbarth GS; Jasinski JM
    Endocrinol Metab Clin North Am; 2004 Mar; 33(1):59-73, viii. PubMed ID: 15053895
    [No Abstract]   [Full Text] [Related]  

  • 5. Normal incidence of diabetes in NOD mice tolerant to glutamic acid decarboxylase.
    Jaeckel E; Klein L; Martin-Orozco N; von Boehmer H
    J Exp Med; 2003 Jun; 197(12):1635-44. PubMed ID: 12796471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Islet cell antigens in insulin-dependent diabetes: Pandora's box revisited.
    Harrison LC
    Immunol Today; 1992 Sep; 13(9):348-52. PubMed ID: 1466752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlling the controls: GAD65 autoreactive T cells in type 1 diabetes.
    Lernmark A
    J Clin Invest; 2002 Apr; 109(7):869-70. PubMed ID: 11927613
    [No Abstract]   [Full Text] [Related]  

  • 8. Thymic expression of mutated B16:A preproinsulin messenger RNA does not reverse acceleration of NOD diabetes associated with insulin 2 (thymic expressed insulin) knockout.
    Nakayama M; Babaya N; Miao D; Sikora K; Elliott JF; Eisenbarth GS
    J Autoimmun; 2005 Nov; 25(3):193-8. PubMed ID: 16289958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoimmune diabetes: is GAD the culprit?
    Lopez-Liuchi JV
    Eur J Endocrinol; 1999 Nov; 141(5):458-9. PubMed ID: 10576760
    [No Abstract]   [Full Text] [Related]  

  • 10. The glutamate decarboxylase and 38KD autoantigens in type 1 diabetes: aspects of structure and epitope recognition.
    Baekkeskov S; Aanstoot HJ; Fu Q; Jaffe M; Kim J; Quan J; Richter W; Shi Y
    Autoimmunity; 1993; 15 Suppl():24-6. PubMed ID: 7692998
    [No Abstract]   [Full Text] [Related]  

  • 11. [Mechanisms of human glutamic acid decarboxylase 65 DNA vaccine preventing diabetes in non-obese diabetic mice].
    Luo JH; Zhou ZG; Jiang TJ; Pei JH; Li X; He L; Sun SG
    Zhonghua Yi Xue Za Zhi; 2004 Nov; 84(21):1791-5. PubMed ID: 15631776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin-specific tolerance in diabetes.
    Gottlieb PA; Eisenbarth GS
    Clin Immunol; 2002 Jan; 102(1):2-11. PubMed ID: 11781061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (Pro)insulin-specific regulatory T cells.
    Harrison LC; Solly NR; Martinez NR
    Novartis Found Symp; 2003; 252():132-41; discussion 141-5, 203-10. PubMed ID: 14609216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The TCR-HA, INS-HA transgenic model of autoimmune diabetes: limitations and expectations.
    Apostolou I; Von Boehmer H
    J Autoimmun; 2004 Mar; 22(2):111-4. PubMed ID: 14987738
    [No Abstract]   [Full Text] [Related]  

  • 15. Differential immune response to B:9-23 insulin 1 and insulin 2 peptides in animal models of type 1 diabetes.
    Devendra D; Paronen J; Moriyama H; Miao D; Eisenbarth GS; Liu E
    J Autoimmun; 2004 Aug; 23(1):17-26. PubMed ID: 15236749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the pathogenicity of autoantigen-specific T-cell receptors.
    Burton AR; Vincent E; Arnold PY; Lennon GP; Smeltzer M; Li CS; Haskins K; Hutton J; Tisch RM; Sercarz EE; Santamaria P; Workman CJ; Vignali DA
    Diabetes; 2008 May; 57(5):1321-30. PubMed ID: 18299317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of autoimmune diabetes through insulin (but not GAD65) DNA vaccination in nonobese diabetic and in RIP-B7.1 mice.
    Karges W; Pechhold K; Al Dahouk S; Riegger I; Rief M; Wissmann A; Schirmbeck R; Barth C; Boehm BO
    Diabetes; 2002 Nov; 51(11):3237-44. PubMed ID: 12401715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD4+CD25+ regulatory T cells control the progression from periinsulitis to destructive insulitis in murine autoimmune diabetes.
    Ott PA; Anderson MR; Tary-Lehmann M; Lehmann PV
    Cell Immunol; 2005 May; 235(1):1-11. PubMed ID: 16122720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice.
    Cooke A; Mandel TE
    J Endocrinol Invest; 1994; 17(7):586-93. PubMed ID: 7829835
    [No Abstract]   [Full Text] [Related]  

  • 20. Peptide-pulsed immature dendritic cells reduce response to beta cell target antigens and protect NOD recipients from type I diabetes.
    Lo J; Peng RH; Barker T; Xia CQ; Clare-Salzler MJ
    Ann N Y Acad Sci; 2006 Oct; 1079():153-6. PubMed ID: 17130547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.